These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
702 related items for PubMed ID: 26627577
1. Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis. Boch T, Buchheidt D, Spiess B, Miethke T, Hofmann WK, Reinwald M. Mycoses; 2016 Feb; 59(2):80-5. PubMed ID: 26627577 [Abstract] [Full Text] [Related]
5. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients. Lahmer T, Neuenhahn M, Held J, Rasch S, Schmid RM, Huber W. J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024 [Abstract] [Full Text] [Related]
6. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis. Danpornprasert P, Foongladda S, Tscheikuna J. J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562 [Abstract] [Full Text] [Related]
7. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients. Nguyen MH, Leather H, Clancy CJ, Cline C, Jantz MA, Kulkarni V, Wheat LJ, Wingard JR. Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680 [Abstract] [Full Text] [Related]
9. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients]. Özger S, Hızel K, Kalkancı A, Aydoğdu M, Civil F, Dizbay M, Gürsel G. Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414 [Abstract] [Full Text] [Related]
10. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. Park SY, Lee SO, Choi SH, Sung H, Kim MN, Choi CM, Hong SB, Oh YM, Shim TS, Koh Y, Kim YS, Woo JH, Kim SH. J Infect; 2010 Dec; 61(6):492-8. PubMed ID: 20833201 [Abstract] [Full Text] [Related]
11. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis. Johnson GL, Sarker SJ, Nannini F, Ferrini A, Taylor E, Lass-Flörl C, Mutschlechner W, Bustin SA, Agrawal SG. J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568 [Abstract] [Full Text] [Related]
12. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies. Heng SC, Chen SC, Morrissey CO, Thursky K, Manser RL, De Silva HD, Halliday CL, Seymour JF, Nation RL, Kong DC, Slavin MA. Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294 [Abstract] [Full Text] [Related]
13. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. Hoenigl M, Prattes J, Spiess B, Wagner J, Prueller F, Raggam RB, Posch V, Duettmann W, Hoenigl K, Wölfler A, Koidl C, Buzina W, Reinwald M, Thornton CR, Krause R, Buchheidt D. J Clin Microbiol; 2014 Jun; 52(6):2039-45. PubMed ID: 24671798 [Abstract] [Full Text] [Related]
14. Testing the performance of a prototype lateral flow device using bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in high-risk patients. Castillo CG, Kauffman CA, Zhai J, Jiang H, Agozino SM, Miceli MH. Mycoses; 2018 Jan; 61(1):4-10. PubMed ID: 28905439 [Abstract] [Full Text] [Related]
15. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance. Racil Z, Kocmanova I, Toskova M, Buresova L, Weinbergerova B, Lengerova M, Rolencova M, Winterova J, Hrncirova K, Volfova P, Skrickova J, Mayer J. Int J Infect Dis; 2011 Dec; 15(12):e874-81. PubMed ID: 22040924 [Abstract] [Full Text] [Related]
16. Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis. Jung J, Kim MY, Chong YP, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH. J Microbiol Immunol Infect; 2018 Dec; 51(6):802-809. PubMed ID: 28712819 [Abstract] [Full Text] [Related]
17. Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies. Luong ML, Filion C, Labbé AC, Roy J, Pépin J, Cadrin-Tourigny J, Carignan S, Sheppard DC, Laverdière M. Diagn Microbiol Infect Dis; 2010 Oct; 68(2):132-9. PubMed ID: 20846585 [Abstract] [Full Text] [Related]
18. Diagnostic yield of a bronchoalveolar lavage fluid galactomannan assay in patients with negative serum galactomannan results suspected to have invasive pulmonary aspergillosis. Lim SY, Lee YW, Jung J, Kim MJ, Chong YP, Lee SO, Choi SH, Kim YS, Choi EJ, Park HS, Lee JH, Lee JH, Lee KH, Kim SH. Mycoses; 2021 Sep; 64(9):1124-1131. PubMed ID: 33740824 [Abstract] [Full Text] [Related]
19. The utility of galactomannan antigen in the bronchial washing and serum for diagnosing pulmonary aspergillosis. Kono Y, Tsushima K, Yamaguchi K, Kurita N, Soeda S, Fujiwara A, Sugiyama S, Togashi Y, Kasagi S, To M, To Y, Setoguchi Y. Respir Med; 2013 Jul; 107(7):1094-100. PubMed ID: 23632100 [Abstract] [Full Text] [Related]
20. [Galactomannan Tests of Bronchoalveolar Lavage Fluid for Diagnosing Invasive Pulmonary Aspergillosis]. Deng J, Wu SY, Liu Y, Ma Y, Xie Y, Chen ZX, Dai ZQ, Deng JL, Kang M. Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):124-128. PubMed ID: 29737102 [Abstract] [Full Text] [Related] Page: [Next] [New Search]